There’s no “I” in “Nutramax”
This article was originally published in The Tan Sheet
Cosamin DS joint health supplement maker Nutramax is challenging a trademark application for Nutrimax in the U.S. for the same class of products registered under its brand name, the Edgewood, Md.-based company announces. The firm filed an opposition with the U.S. Patent and Trademark Office as well as a court complaint citing trademark infringement. The U.S. District Court for the District of Maryland July 17 granted the firm's motion for judgment by default effectively barring Los Angeles-based Nutrimax USA from advertising, promoting and/or offering to market any dietary supplement products containing the word "Nutrimax," and requires it to destroy all documents containing the word and modify all Web sites and electronic files...
You may also be interested in...
CHF Solutions adds “CEO” to its president’s job title; Agilent VP of business development promoted to senior VP; Zimmer hires chief transformation officer; and more.
Pfizer has pressed on with the launch of a fourth biosimilar pegfilgrastim product, Nyvepria (pegfilgrastim-apgf), according to an investment bank. With Amgen continuing to hold more than 70% of the market, there is opportunity for Pfizer to capture significant market share.
EU Business Round-Up: Galenica Boosted By Deals, Alliance's Sales Rise, And Beiersdorf Relaunches Wound Care
Latest EU business news: Galenica posts sales up in 2020 thanks to deals; Alliance Pharma's Consumer sales edge up despite COVID-19; and Beiersdorf is relaunching its wound care range with sustainability in mind.